CHAPEL HILL, N.C., July 23 /PRNewswire/ — The
bio-pharmaceutical marketplace – and the oncology therapeutic
area in particular – continues to evolve as new medicines and
technologies create valuable market opportunities. It’s in this
competitive and challenging environment that organizations with new
oncology products are scrutinizing their strategies and tactics to
support market education.
Many medical affairs executives focused on the oncology
therapeutic area commence national thought leader relationship
seeding during the pre-clinical stage whereas other therapeutic
areas often start at Phase I, according to research from Best
Practices, LLC. In oncology, once relationships are established
with national thought leaders, relationship development activities
are extended in Phase III to the cascade of regional thought
leaders, key influencers and key payers.
The report, Shaping the
Marketplace to Support Successful Oncology Product Launches:
Tactics for Educating KOLs, Physicians, Patients and Payers,
contains a plethora of benchmark metrics on the most effective
physician, payer and patient education practices conducted from
clinical development through launch. The 150-page report contains
almost 500 metrics to help inform launch leaders in the oncology
area on the most effective type and timing of market education
practices during the full development cycle.
The research – which includes oncology and total benchmark class
segments – attracted 34 executives and managers from 26 leading
pharmaceutical, biotech and medical device companies includ
‘/>”/>
